SEC filings
Moderna (MRNA)
Recent filings Moderna made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0001682852All filings on SEC.gov
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Regulation FD Disclosure
Moderna appointed Juan Andres as its first Chief Operating Officer, effective October 5, 2026, reporting to CEO Stéphane Bancel and serving on the Executive Committee, and said Chief Technical Operations and Quality Officer Jerh Collins…
8-KCurrent report
Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant …
Moderna completed a private offering of $3.0 billion aggregate principal amount of 0.00% convertible senior notes due 2032, including the full exercise of an option to purchase up to an additional $400 million. …
10-QQuarterly report
Quarterly report
Moderna reported a second-quarter 2026 net loss of $782 million, narrower than the $825 million loss a year earlier, on total revenue of $145 million, while its first-half net loss widened to $2.13 billion from $1.80 billion. …
8-KCurrent report
Results of Operations and Financial Condition
Moderna reported second-quarter 2026 total revenue of $145 million and a GAAP net loss of $0.8 billion, reiterated its plan for up to 10% revenue growth in 2026, and improved its full-year operating expense and year-end cash outlook to…
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow Moderna in Readster
Add Moderna to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.